{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"citrin-deficiency","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"Citrin deficiency can manifest in newborns or infants as neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD), in older children as failure to thrive and dyslipidemia caused by citrin deficiency (FTTDCD), and in adults as recurrent hyperammonemia with neuropsychiatric symptoms in citrullinemia type II (CTLN2). Often citrin deficiency is characterized by strong preference for protein-rich and/or lipid-rich foods and aversion to carbohydrate-rich foods.","mondoId":"MONDO:0016602","node":{"canonicalSlug":"citrin-deficiency","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","matchMethod":"automatic-preferred-title","name":"Citrin Deficiency","paragraphs":["Citrin deficiency can manifest in newborns or infants as neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD), in older children as failure to thrive and dyslipidemia caused by citrin deficiency (FTTDCD), and in adults as recurrent hyperammonemia with neuropsychiatric symptoms in citrullinemia type II (CTLN2). Often citrin deficiency is characterized by strong preference for protein-rich and/or lipid-rich foods and aversion to carbohydrate-rich foods.","*NICCD:* Children younger than age one year have a history of low birth weight with growth restriction and transient intrahepatic cholestasis, hepatomegaly, diffuse fatty liver, and parenchymal cellular infiltration associated with hepatic fibrosis, variable liver dysfunction, hypoproteinemia, decreased coagulation factors, anemia, and/or hypoglycemia. NICCD is generally not severe, and clinical manifestations are often resolved by age one year with appropriate treatment, although liver failure may still occur; liver transplantation has been required in rare instances.","*FTTDCD:* Beyond age one year, many children with citrin deficiency develop a protein-rich and/or lipid-rich food preference and aversion to carbohydrate-rich foods. Clinical abnormalities may include poor weight gain, growth deficiency, severe fatigue, anorexia, and impaired quality of life. Laboratory changes are dyslipidemia, recurrent hypoglycemia, increased lactate-to-pyruvate ratio, higher levels of urinary oxidative stress markers, and considerable deviation in tricarboxylic acid cycle metabolites. One or more decades later, some adults with NICCD or FTTDCD may progress and develop features of CTLN2.","*CTLN2:* Presentation is sudden and usually between ages 20 and 50 years. Clinical manifestations include recurrent hyperammonemia with neuropsychiatric (aggression, irritability, restlessness, hyperactivity, delusions, nocturnal delirium) and neurologic manifestations (flapping tremors, memory loss, disorientation, drowsiness, convulsive seizures, coma). Clinical manifestations are often caused by alcohol and sugar intake, medication, and/or surgery. Complications include severe liver steatosis and pancreatitis. Affected individuals may or may not have a prior history of NICCD or FTTDCD."],"reviewed":"2025-03-20","scope":"exact","source":"GeneReviews","sourceExcerpt":"Summary / Clinical characteristics","sourceRelease":"2026-10-18 12:07:28.061962+00","upstream":"GeneReviews clinical characteristics","url":"https://www.ncbi.nlm.nih.gov/books/NBK1181/"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"citrullinemia","mondoId":"MONDO:0015991","slug":"citrullinemia"},{"kind":"parent","label":"urea cycle disorder or inherited hyperammonemia","mondoId":"MONDO:0800153","slug":"urea-cycle-disorder-or-inherited-hyperammonemia"},{"kind":"child","label":"neonatal intrahepatic cholestasis due to citrin deficiency","mondoId":"MONDO:0011601","slug":"neonatal-intrahepatic-cholestasis-due-to-citrin-deficiency"},{"kind":"child","label":"citrullinemia type II","mondoId":"MONDO:0016603","slug":"citrullinemia-type-ii"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK1181/\" rel=\"noreferrer\">GeneReviews</a></p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/20661\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0016602\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-preferred-title</dd><dt>Upstream attribution</dt><dd>GeneReviews clinical characteristics</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Citrin deficiency can manifest in newborns or infants as neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD), in older children as failure to thrive and dyslipidemia caused by citrin deficiency (FTTDCD), and in adults as recurrent hyperammonemia with neuropsychiatric symptoms in citrullinemia type II (CTLN2). Often citrin deficiency is characterized by strong preference for protein-rich and/or lipid-rich foods and aversion to carbohydrate-rich foods.</p><p>*NICCD:* Children younger than age one year have a history of low birth weight with growth restriction and transient intrahepatic cholestasis, hepatomegaly, diffuse fatty liver, and parenchymal cellular infiltration associated with hepatic fibrosis, variable liver dysfunction, hypoproteinemia, decreased coagulation factors, anemia, and/or hypoglycemia. NICCD is generally not severe, and clinical manifestations are often resolved by age one year with appropriate treatment, although liver failure may still occur; liver transplantation has been required in rare instances.</p><p>*FTTDCD:* Beyond age one year, many children with citrin deficiency develop a protein-rich and/or lipid-rich food preference and aversion to carbohydrate-rich foods. Clinical abnormalities may include poor weight gain, growth deficiency, severe fatigue, anorexia, and impaired quality of life. Laboratory changes are dyslipidemia, recurrent hypoglycemia, increased lactate-to-pyruvate ratio, higher levels of urinary oxidative stress markers, and considerable deviation in tricarboxylic acid cycle metabolites. One or more decades later, some adults with NICCD or FTTDCD may progress and develop features of CTLN2.</p><p>*CTLN2:* Presentation is sudden and usually between ages 20 and 50 years. Clinical manifestations include recurrent hyperammonemia with neuropsychiatric (aggression, irritability, restlessness, hyperactivity, delusions, nocturnal delirium) and neurologic manifestations (flapping tremors, memory loss, disorientation, drowsiness, convulsive seizures, coma). Clinical manifestations are often caused by alcohol and sugar intake, medication, and/or surgery. Complications include severe liver steatosis and pancreatitis. Affected individuals may or may not have a prior history of NICCD or FTTDCD.</p><p class=\"section-source\">Source: <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK1181/\" rel=\"noreferrer\">GeneReviews</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"citrin-deficiency","sourceDocuments":[{"name":"GeneReviews: Citrin Deficiency","reviewed":"2025-03-20","source_release":"2026-10-18 12:07:28.061962+00","url":"https://www.ncbi.nlm.nih.gov/books/NBK1181/"},{"name":"GARD: Citrin deficiency","reviewed":null,"source_release":"2026-10-25T03:43:03Z","url":"https://rarediseases.info.nih.gov/diseases/20661"},{"name":"MONDO: citrin deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0016602"}],"sourceNote":"","synonyms":["citrin deficiency"],"takeawayHtml":"","title":"citrin deficiency"},"schemaVersion":1}
